Export 2757 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
A. F. Holtyn, Bosworth, E., Marsch, L. A., McLeman, B., Meier, A., Saunders, E. C., Ertin, E., Ullah, M. Azim, Samiei, S. Alan, Hossain, M., Kumar, S., Preston, K. L., Vahabzadeh, M., Shmueli-Blumberg, D., Collins, J., McCormack, J., and Ghitza, U. E., Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology., Contemp Clin Trials Commun, vol. 15, p. 100392, 2019.
P. R. Thomas, Lindblad, A. S., Stablein, D. M., Knowlton, A. H., Bruckner, H. W., Childs, D. S., and Mittelman, A., Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum., Cancer, vol. 57, no. 6, pp. 1130-4, 1986.
G. Sharma, Van Veldhuisen, P., and Allen, C. A., Tracking and Monitoring Trial Progress in NIDA CTN Studies, in NIH Workshop on Enrollment and Retention of Participants in NIH-funded Clinical Trials, Bethesda, MD, 2014.
S. Schenning, McBee, W. L., Clemons, T. E., Chew, E. Y., and SanGiovanni, J. P., Tracking of regulatory documents in a large clinical trial, The Age-Related Eye Disease Study 2, in Society for Clinical Trials, Miami, FL, 2012.
E. Shemesh, Duncan, S., Anand, R., Shneider, B. L., Alonso, E. M., Mazariegos, G. V., Venick, R. S., Annunziato, R. A., and Bucuvalas, J. C., Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort., Liver Transpl, vol. 24, no. 1, pp. 80-88, 2018.
R. Kosoy, Agashe, C., Grishin, A., Leung, D. Y., Wood, R. A., Sicherer, S. H., Jones, S. M., A Burks, W., Davidson, W. F., Lindblad, R. W., Dawson, P., Merad, M., Kidd, B. A., Dudley, J. T., Sampson, H. A., and M Berin, C., Transcriptional Profiling of Egg Allergy and Relationship to Disease Phenotype., PLoS One, vol. 11, no. 10, p. e0163831, 2016.
J. B. Goll, Li, S., Edwards, J. L., Bosinger, S. E., Jensen, T. L., Wang, Y., Hooper, W. F., Gelber, C. E., Sanders, K. L., Anderson, E. J., Rouphael, N., Natrajan, M. S., Johnson, R. A., Sanz, P., Hoft, D., and Mulligan, M. J., Transcriptomic and Metabolic Responses to a Live-Attenuated Vaccine., Vaccines (Basel), vol. 8, no. 3, 2020.
A. W. Heldman, DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., Ghersin, E., Soto, V., ,, Da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., and Hare, J. M., Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial, JAMA, vol. 311, pp. 62-73, 2014.
J. Harris, Chaney, K., Salazar, D., Ward, A., and Shmueli-Blumberg, D., Transition from On-Site to Remote Site Initiation Activities, in Society of Clinical Research Associates (SOCRA), Virtual, 2021.
C. Kim, King, D., Chamberlain, J., Clemons, T., and Brandt, D., Transitioning Paper to Electronic Case Report Forms Mid-Study From One Clinical Research Organization to Another, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
L. Revoredo, Lewis, M., Shmueli-Blumberg, D., and Jelstrom, E., Transitioning to the Remote Collection of Urine Specimens for Urine Drug Screening During COVID-19., in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
R. Leslie, Lewis, M., Shmueli-Blumberg, D., and Jelstrom, E., Transitioning to the Remote Collection of Urine Specimens for Urine Drug Screening During COVID-19. 2021.
J. Alexander, Metze, T., Goodman, H., McIntosh, M., Zeng, L., Cardi, M., Austin, J., Goel, S., Safdar, S., Greenburg, N., and Woodle, E., Transplant Success and Immunodulating Diets, 2003.
J. M. Palefsky, Lee, J. Y., Jay, N., Goldstone, S. E., Darragh, T. M., Dunlevy, H. A., Rosa-Cunha, I., Arons, A., Pugliese, J. C., Vena, D., Sparano, J. A., Wilkin, T. J., Bucher, G., Stier, E. A., Gomez, M. Tirado, Flowers, L., Barroso, L. F., Mitsuyasu, R. T., Lensing, S. Y., Logan, J., Aboulafia, D. M., Schouten, J. T., de la Ossa, J., Levine, R., Korman, J. D., Hagensee, M., Atkinson, T. M., Einstein, M. H., Cracchiolo, B. M., Wiley, D., Ellsworth, G. B., Brickman, C., and J Berry-Lawhorn, M., Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer., N Engl J Med, vol. 386, no. 24, pp. 2273-2282, 2022.
W. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C., Cukras, C., Chew, E., Sadda, S., and Ferris, F., Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
W. T. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C. B., Cukras, C., Chew, E. Y., Sadda, S. V. R., and Ferris, F. L., Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial., Invest Ophthalmol Vis Sci, vol. 51, no. 12, pp. 6131-9, 2010.
G. Gensler, Clemons, T. E., Domalpally, A., Danis, R. P., Blodi, B., Wells, J., Rauser, M., Hoskins, J., G Hubbard, B., Elman, M. J., Fish, G. E., Brucker, A., Margherio, A., and Chew, E. Y., Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study., Ophthalmol Retina, vol. 2, no. 5, pp. 441-450, 2018.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C. A., Ferris, F. L., and Chew, E. Y., Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial., Invest Ophthalmol Vis Sci, vol. 54, no. 4, pp. 2941-50, 2013.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C., Ferris, F. L., and Chew, E. Y., Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial, Invest Ophthalmol Vis Sci, vol. 54, pp. 2941-2950, 2013.
B. D. Cheson, Sorensen, J. M., Vena, D. A., Montello, M. J., Barrett, J. A., Damasio, E., Tallman, M., Annino, L., Connors, J., Coiffier, B., and Lauria, F., Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients., J Clin Oncol, vol. 16, no. 9, pp. 3007-15, 1998.
J. Smith, Thompson, D., Whitcup, S., Suhler, E., Clarke, G., Robinson, M., and Baron, K., The treatment of JRA-associated uveitis with Etanercept, 2002.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial, Proceedings of the National Academy of Science USA, vol. 96, pp. 7462-66, 1999.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial., Proc Natl Acad Sci U S A, vol. 96, no. 13, pp. 7462-6, 1999.
E. Atallah, Bylow, K., Troy, J., and Saber, W., Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT)., Curr Hematol Malig Rep, vol. 9, no. 1, pp. 57-65, 2014.
E. Atallah, Bylow, K., Troy, J., and W, S., Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): the Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT), Curr Hematol Malig Rep, vol. 9, pp. 57-65, 2014.